Selected research
Market Structure
Global Urine Drug Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Urine Drug Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Urine Drug Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Urine Drug Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Urine Drug Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Urine Drug Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Urine Drug Testing Service include Abbott, Labcorp, Quest Diagnostics, Millennium Health, Genesis Reference Labs, Concentra, DISA, Medigold Health and Keystone Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Urine Drug Testing Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Urine Drug Testing Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Urine Drug Testing Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Urine Drug Testing Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Urine Drug Testing Service Segment by Company
Abbott
Labcorp
Quest Diagnostics
Millennium Health
Genesis Reference Labs
Concentra
DISA
Medigold Health
Keystone Laboratories
Crystal Health
MedTox
Australian Clinical Labs
Dominion Diagnostics
Matrix Diagnostics
Dorevitch Pathology
Urine Drug Testing Service Segment by Type
On-site Testing
Laboratory-based Testing
Urine Drug Testing Service Segment by Application
Hospital
Clinic
Others
Urine Drug Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urine Drug Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Urine Drug Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urine Drug Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Urine Drug Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Urine Drug Testing Service industry.
Chapter 3: Detailed analysis of Urine Drug Testing Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urine Drug Testing Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- On-site Testing
- Laboratory-based Testing
Applications
- Hospital
- Clinic
- Others
Companies covered
- Abbott
- Labcorp
- Quest Diagnostics
- Millennium Health
- Genesis Reference Labs
- Concentra
- DISA
- Medigold Health
- Keystone Laboratories
- Crystal Health
- MedTox
- Australian Clinical Labs
- Dominion Diagnostics
- Matrix Diagnostics
- Dorevitch Pathology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Urine Drug Testing Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 On-site Testing
- 1.2.3 Laboratory-based Testing
- 1.3 Market Analysis by Application
- 1.3.1 Global Urine Drug Testing Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Urine Drug Testing Service Growth Trends by Region
- 1.5.1 Global Urine Drug Testing Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Urine Drug Testing Service Market Size by Region (2021-2026)
- 1.5.3 Urine Drug Testing Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Urine Drug Testing Service Market Dynamics
- 2.1 Urine Drug Testing Service Industry Trends
- 2.2 Urine Drug Testing Service Industry Drivers
- 2.3 Urine Drug Testing Service Industry Opportunities and Challenges
- 2.4 Urine Drug Testing Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Urine Drug Testing Service Revenue by Company (2021-2026)
- 3.2 Global Urine Drug Testing Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Urine Drug Testing Service Key Company Head office and Area Served
- 3.4 Global Urine Drug Testing Service Company, Product Type & Application
- 3.5 Global Urine Drug Testing Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Urine Drug Testing Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Urine Drug Testing Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Urine Drug Testing Service Tier 1, Tier 2, and Tier 3
4 Urine Drug Testing Service Market by Type
- 4.1 Global Urine Drug Testing Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Urine Drug Testing Service Market Size by Type (2021-2032)
- 4.3 Global Urine Drug Testing Service Market Size Share by Type (2021-2032)
5 Urine Drug Testing Service Market by Application
- 5.1 Global Urine Drug Testing Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Urine Drug Testing Service Market Size by Application (2021-2032)
- 5.3 Global Urine Drug Testing Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Abbott
- 6.1.1 Abbott Company Information
- 6.1.2 Abbott Business Overview
- 6.1.3 Abbott Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Abbott Urine Drug Testing Service Product Portfolio
- 6.1.5 Abbott Recent Developments
- 6.2 Labcorp
- 6.2.1 Labcorp Company Information
- 6.2.2 Labcorp Business Overview
- 6.2.3 Labcorp Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Labcorp Urine Drug Testing Service Product Portfolio
- 6.2.5 Labcorp Recent Developments
- 6.3 Quest Diagnostics
- 6.3.1 Quest Diagnostics Company Information
- 6.3.2 Quest Diagnostics Business Overview
- 6.3.3 Quest Diagnostics Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Quest Diagnostics Urine Drug Testing Service Product Portfolio
- 6.3.5 Quest Diagnostics Recent Developments
- 6.4 Millennium Health
- 6.4.1 Millennium Health Company Information
- 6.4.2 Millennium Health Business Overview
- 6.4.3 Millennium Health Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Millennium Health Urine Drug Testing Service Product Portfolio
- 6.4.5 Millennium Health Recent Developments
- 6.5 Genesis Reference Labs
- 6.5.1 Genesis Reference Labs Company Information
- 6.5.2 Genesis Reference Labs Business Overview
- 6.5.3 Genesis Reference Labs Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Genesis Reference Labs Urine Drug Testing Service Product Portfolio
- 6.5.5 Genesis Reference Labs Recent Developments
- 6.6 Concentra
- 6.6.1 Concentra Company Information
- 6.6.2 Concentra Business Overview
- 6.6.3 Concentra Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Concentra Urine Drug Testing Service Product Portfolio
- 6.6.5 Concentra Recent Developments
- 6.7 DISA
- 6.7.1 DISA Company Information
- 6.7.2 DISA Business Overview
- 6.7.3 DISA Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 DISA Urine Drug Testing Service Product Portfolio
- 6.7.5 DISA Recent Developments
- 6.8 Medigold Health
- 6.8.1 Medigold Health Company Information
- 6.8.2 Medigold Health Business Overview
- 6.8.3 Medigold Health Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Medigold Health Urine Drug Testing Service Product Portfolio
- 6.8.5 Medigold Health Recent Developments
- 6.9 Keystone Laboratories
- 6.9.1 Keystone Laboratories Company Information
- 6.9.2 Keystone Laboratories Business Overview
- 6.9.3 Keystone Laboratories Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Keystone Laboratories Urine Drug Testing Service Product Portfolio
- 6.9.5 Keystone Laboratories Recent Developments
- 6.10 Crystal Health
- 6.10.1 Crystal Health Company Information
- 6.10.2 Crystal Health Business Overview
- 6.10.3 Crystal Health Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Crystal Health Urine Drug Testing Service Product Portfolio
- 6.10.5 Crystal Health Recent Developments
- 6.11 MedTox
- 6.11.1 MedTox Company Information
- 6.11.2 MedTox Business Overview
- 6.11.3 MedTox Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 MedTox Urine Drug Testing Service Product Portfolio
- 6.11.5 MedTox Recent Developments
- 6.12 Australian Clinical Labs
- 6.12.1 Australian Clinical Labs Company Information
- 6.12.2 Australian Clinical Labs Business Overview
- 6.12.3 Australian Clinical Labs Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Australian Clinical Labs Urine Drug Testing Service Product Portfolio
- 6.12.5 Australian Clinical Labs Recent Developments
- 6.13 Dominion Diagnostics
- 6.13.1 Dominion Diagnostics Company Information
- 6.13.2 Dominion Diagnostics Business Overview
- 6.13.3 Dominion Diagnostics Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Dominion Diagnostics Urine Drug Testing Service Product Portfolio
- 6.13.5 Dominion Diagnostics Recent Developments
- 6.14 Matrix Diagnostics
- 6.14.1 Matrix Diagnostics Company Information
- 6.14.2 Matrix Diagnostics Business Overview
- 6.14.3 Matrix Diagnostics Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Matrix Diagnostics Urine Drug Testing Service Product Portfolio
- 6.14.5 Matrix Diagnostics Recent Developments
- 6.15 Dorevitch Pathology
- 6.15.1 Dorevitch Pathology Company Information
- 6.15.2 Dorevitch Pathology Business Overview
- 6.15.3 Dorevitch Pathology Urine Drug Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Dorevitch Pathology Urine Drug Testing Service Product Portfolio
- 6.15.5 Dorevitch Pathology Recent Developments
7 North America
- 7.1 North America Urine Drug Testing Service Market Size (2021-2032)
- 7.2 North America Urine Drug Testing Service Market Size by Type
- 7.2.1 North America Urine Drug Testing Service Market Size by Type (2021-2026)
- 7.2.2 North America Urine Drug Testing Service Market Size by Type (2027-2032)
- 7.2.3 North America Urine Drug Testing Service Market Share by Type (2021-2032)
- 7.3 North America Urine Drug Testing Service Market Size by Application
- 7.3.1 North America Urine Drug Testing Service Market Size by Application (2021-2026)
- 7.3.2 North America Urine Drug Testing Service Market Size by Application (2027-2032)
- 7.3.3 North America Urine Drug Testing Service Market Share by Application (2021-2032)
- 7.4 North America Urine Drug Testing Service Market Size by Country
- 7.4.1 North America Urine Drug Testing Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Urine Drug Testing Service Market Size by Country (2021-2026)
- 7.4.3 North America Urine Drug Testing Service Market Size by Country (2027-2032)
- 7.4.4 North America Urine Drug Testing Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Urine Drug Testing Service Market Size (2021-2032)
- 8.2 Europe Urine Drug Testing Service Market Size by Type
- 8.2.1 Europe Urine Drug Testing Service Market Size by Type (2021-2026)
- 8.2.2 Europe Urine Drug Testing Service Market Size by Type (2027-2032)
- 8.2.3 Europe Urine Drug Testing Service Market Share by Type (2021-2032)
- 8.3 Europe Urine Drug Testing Service Market Size by Application
- 8.3.1 Europe Urine Drug Testing Service Market Size by Application (2021-2026)
- 8.3.2 Europe Urine Drug Testing Service Market Size by Application (2027-2032)
- 8.3.3 Europe Urine Drug Testing Service Market Share by Application (2021-2032)
- 8.4 Europe Urine Drug Testing Service Market Size by Country
- 8.4.1 Europe Urine Drug Testing Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Urine Drug Testing Service Market Size by Country (2021-2026)
- 8.4.3 Europe Urine Drug Testing Service Market Size by Country (2027-2032)
- 8.4.4 Europe Urine Drug Testing Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Urine Drug Testing Service Market Size (2021-2032)
- 9.2 China Urine Drug Testing Service Market Size by Type
- 9.2.1 China Urine Drug Testing Service Market Size by Type (2021-2026)
- 9.2.2 China Urine Drug Testing Service Market Size by Type (2027-2032)
- 9.2.3 China Urine Drug Testing Service Market Share by Type (2021-2032)
- 9.3 China Urine Drug Testing Service Market Size by Application
- 9.3.1 China Urine Drug Testing Service Market Size by Application (2021-2026)
- 9.3.2 China Urine Drug Testing Service Market Size by Application (2027-2032)
- 9.3.3 China Urine Drug Testing Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Urine Drug Testing Service Market Size (2021-2032)
- 10.2 Asia Urine Drug Testing Service Market Size by Type
- 10.2.1 Asia Urine Drug Testing Service Market Size by Type (2021-2026)
- 10.2.2 Asia Urine Drug Testing Service Market Size by Type (2027-2032)
- 10.2.3 Asia Urine Drug Testing Service Market Share by Type (2021-2032)
- 10.3 Asia Urine Drug Testing Service Market Size by Application
- 10.3.1 Asia Urine Drug Testing Service Market Size by Application (2021-2026)
- 10.3.2 Asia Urine Drug Testing Service Market Size by Application (2027-2032)
- 10.3.3 Asia Urine Drug Testing Service Market Share by Application (2021-2032)
- 10.4 Asia Urine Drug Testing Service Market Size by Country
- 10.4.1 Asia Urine Drug Testing Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Urine Drug Testing Service Market Size by Country (2021-2026)
- 10.4.3 Asia Urine Drug Testing Service Market Size by Country (2027-2032)
- 10.4.4 Asia Urine Drug Testing Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Urine Drug Testing Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Urine Drug Testing Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Urine Drug Testing Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Urine Drug Testing Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Urine Drug Testing Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Urine Drug Testing Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Urine Drug Testing Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Urine Drug Testing Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Urine Drug Testing Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Urine Drug Testing Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Urine Drug Testing Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Urine Drug Testing Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Urine Drug Testing Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Urine Drug Testing Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst